Impact of MRD-negative on PFS in myeloma; IPSS-R down-staging before transplant in MDS; hereditary angioedema and venous thromboembolism
July 25, 202421m 50s
Audio is streamed directly from the publisher (prfx.byspotify.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In this week's episode we'll discuss minimal residual disease as an intermediate clinical endpoint for multiple myeloma. Then, we'll learn about IPSS-R downstaging before transplant in MDS. Finally we'll hear about the connection between hereditary angioedema and venous thromboembolism.
Featured Articles:
- EVIDENCE meta-analysis: evaluating minimal residual disease as an intermediate clinical endpoint for multiple myeloma
- Does IPSS-R down-staging before transplantation improve the prognosis of patients with Myelodysplastic Neoplasms?
- Increased risk of venous thromboembolism [or VTE] in young and middle-aged individuals with hereditary angioedema: a family study
Topics
hematologyoncologymedicalmedical researchlymphomaleukemiaCAR Tred cells